Geode Capital Management’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
Other funds holding BNR
KCM
NAMA
HH
Geode Capital Management's BNR Position: Q2 2024 in Review
Geode Capital Management sold out of Burning Rock Biotech (BNR) in Q2 2024, closing a stake of 2,560 shares — an estimated $18.7K sold.
Geode Capital Management first reported a position in BNR in Q2 2020 and held it in 14 quarters. The position peaked at $4.84M in Q2 2021. 18 funds tracked by Wall St. Rank hold BNR as of Q2 2024.
- Geode Capital Management reported no remaining Burning Rock Biotech position as of Q2 2024 after selling out during the quarter.
- Geode Capital Management sold 2,560 Burning Rock Biotech shares in Q2 2024, an estimated $18.7K.
- Geode Capital Management first reported a position in Burning Rock Biotech in Q2 2020 and held it in 14 quarters.
- Geode Capital Management's Burning Rock Biotech position peaked at $4.84M in Q2 2021.
- 18 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2024.
Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.